Article
Inactivation of the RASSF1A in osteosarcoma.
Oncology reports - 1 Jan 2000
Lim Sungjig, Yang Moon Ho, Park Jae Hoon, Nojima Takayuki, Hashimoto Hiroshi, Unni K Krishnan, Park Yong-Koo
Abstract excerpt
We investigated the expression and mutation of three isoforms of the Ras effector RASSF1 in 10 primary osteosarcomas and 6 osteosarcoma cell lines. RASSF1A was not expressed in 40% (4/10) of the primary osteosarcomas and 83.3% (5/6) of the osteosarcoma cell lines. RASSF1B and RASSF1C expression was absent in 30% (3/10) and 0% (0/10) of primary tumors, and 100% (6/6) and 0% (0/6) of osteosarcoma cell lines,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
